InsiderClue
← All stocks

Immunocore Holdings plc

IMCR Net selling
CIK 0001671927 #2109 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$7.81M
$0.00 on a plan · $7.19M straight out of an exercise
Sold at will
$619.08K
4 of 11 sales
Net
−$7.81M
−$619.08K against sales at will

By person

5 insiders · 11 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Berman David M
HEAD OF R&D
—
$7.39M (8) scheduled
−$7.39M
5,859
0.0114%
$189.54K
—
Jallal Bahija
CHIEF EXECUTIVE OFFICER
—
$371.18K (1)
−$371.18K
12,343
0.0240%
$399.30K
—
St Leger Tina Amber
CHIEF HR OFFICER
—
$32.35K (1)
−$32.35K
1,119
0.0022%
$36.20K
—
GOLL JOHN
SVP, FINANCE & CAO
—
$22.58K (1)
−$22.58K
653
0.0013%
$21.12K
—
BAKER BROS. ADVISORS LP entity
Director
—
—
—
2,144,060
4.16%
$69.36M
+60.4%

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Berman David M
5 Dec 2025
HEAD OF R&D
Sold after exercise
572
$40.14
$22.96K
Berman David M
4 Dec 2025
HEAD OF R&D
Sold after exercise
31,341
$40.26
$1.26M
Berman David M
28 Nov 2025
HEAD OF R&D
Sold after exercise
5,521
$40.09
$221.34K
Berman David M
26 Nov 2025
HEAD OF R&D
Sold after exercise
69,404
$40.12
$2.78M
Berman David M
25 Nov 2025
HEAD OF R&D
Sold after exercise
18,020
$40.03
$721.34K
Berman David M
24 Nov 2025
HEAD OF R&D
Sold after exercise
100
$40.00
$4.00K
Berman David M
30 Sep 2025
HEAD OF R&D
Sold after exercise
61,849
$35.23
$2.18M
Show all 11 transactions →

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 4
Transactions with no price 0
Shares from compensation/vesting 225,918
History held since 5 Jan 2024